NVIV Invivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.

$0.76
As of 06/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/29/2010
Outstanding shares:  34,264,756
Average volume:  615,484
Market cap:   $24,800,830
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    46186M506
ISIN:        US46186M5067
Sedol:      BKT1TJ5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.92
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy